All Stories

  1. MicroRNA-based therapeutics in central nervous system injuries
  2. Inhibition of Src family kinases improves cognitive function after intraventricular hemorrhage or intraventricular thrombin
  3. MicroRNA-122 in Stroke
  4. MicroRNA-mRNA networks in DMD
  5. Inflammation Combined with Ischemia Produces Myelin Injury and Plaque-Like Aggregates of Myelin, Amyloid-β and AβPP in Adult Rat Brain
  6. Intracerebral Hemorrhage and Ischemic Stroke of Different Etiologies Have Distinct Alternatively Spliced mRNA Profiles in the Blood: a Pilot RNA-seq Study
  7. Targeting Neutrophils in Ischemic Stroke: Translational Insights from Experimental Studies
  8. Src Family Kinases in Intracerebral Hemorrhage
  9. Gene Expression in Peripheral Immune Cells following Cardioembolic Stroke Is Sexually Dimorphic
  10. Inhibition of Src Family Kinases Protects Hippocampal Neurons and Improves Cognitive Function after Traumatic Brain Injury
  11. microRNA Expression in Peripheral Blood Cells following Acute Ischemic Stroke and Their Predicted Gene Targets
  12. Myelin Injury and Degraded Myelin Vesicles in Alzheimer’s Disease
  13. Distinctive RNA Expression Profiles in Blood Associated With Alzheimer Disease After Accounting for White Matter Hyperintensities
  14. Hemorrhagic Transformation after Ischemic Stroke in Animals and Humans
  15. Blood Genomics After Brain Ischemia, Hemorrhage, and Trauma
  16. RNA in blood is altered prior to hemorrhagic transformation in ischemic stroke
  17. Heat Shock Proteins in the Brain: Role of Hsp70, Hsp 27, and HO-1 (Hsp32) and Their Therapeutic Potential
  18. Y Chromosome Gene Expression in the Blood of Male Patients With Ischemic Stroke Compared With Male Controls
  19. Excitatory and Mitogenic Signaling in Cell Death, Blood–brain Barrier Breakdown, and BBB Repair after Intracerebral Hemorrhage
  20. Integrated analysis of mRNA and microRNA expression in mature neurons, neural progenitor cells and neuroblastoma cells
  21. Ischemic Transient Neurological Events Identified by Immune Response to Cerebral Ischemia
  22. MicroRNA Expression Profiling of Rat Blood and Brain Tissues: TaqMan Real-Time PCR MicroRNA Assays
  23. Cell Cycle Inhibition without Disruption of Neurogenesis Is a Strategy for Treatment of Aberrant Cell Cycle Diseases: An Update
  24. Effects of Gender on Gene Expression in the Blood of Ischemic Stroke Patients
  25. Profiles of lacunar and nonlacunar stroke
  26. Molecular markers and mechanisms of stroke: RNA studies of blood in animals and humans
  27. GABA- and acetylcholine-related gene expression in blood correlate with tic severity and microarray evidence for alternative splicing in Tourette syndrome: A pilot study
  28. The Dual Role of Src Kinases in Intracerebral Hemorrhage
  29. Differences in exon expression and alternatively spliced genes in blood of multiple sclerosis compared to healthy control subjects
  30. Cell Cycle Phase Transitions: Signposts for Aberrant Cell Cycle Reentry in Dying Mature Neurons
  31. Exon expression and alternatively spliced genes in tourette syndrome
  32. Signatures of cardioembolic and large-vessel ischemic stroke
  33. Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of central nervous system diseases
  34. Genome response to tissue plasminogen activator in experimental ischemic stroke
  35. Blood-brain barrier breakdown and repair by Src after thrombin-induced injury
  36. Brief Focal Cerebral Ischemia That Simulates Transient Ischemic Attacks in Humans Regulates Gene Expression in Rat Peripheral Blood
  37. Brain and Blood microRNA Expression Profiling of Ischemic Stroke, Intracerebral Hemorrhage, and Kainate Seizures
  38. Identification and validation of suitable endogenous reference genes for gene expression studies in human peripheral blood
  39. Src kinase inhibition decreases thrombin-induced injury and cell cycle re-entry in striatal neurons
  40. Gene Expression in Peripheral Blood Differs after Cardioembolic Compared with Large-Vessel Atherosclerotic Stroke: Biomarkers for the Etiology of Ischemic Stroke
  41. The Future of Genomic Profiling of Neurological Diseases Using Blood